Multi-country

AI can flag hidden cardiac risk. The dangerous part is what health systems do next

Down Syndrome Cannot Stay Outside Alzheimer’s Trials

More Children Got A First Vaccine. Millions Still Fell Out Of The System.

AstraZeneca’s heart drug failure raises a brutal question: how much treatment is too much treatment?

Radioligand Therapy Is Building Its Evidence Base. Now Build the Infrastructure.

Tau Is Back. Certainty Is Not.

Gonorrhoea Is Learning To Beat Ceftriaxone. Europe Must Move First.

Why some “resistant” hypertension isn’t resistant at all, and what cardiology might be missing

Pancreatic Cancer Is Forcing Regulators to Move Faster
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
